Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC ‘exasperated’ that pharmacy’s COVID costs ignored in budget

The fact that the government failed to commit to covering pharmacy’s COVID costs in today’s budget is “exasperating and disappointing”, PSNC chief Simon Dukes has said.

Ahead of today’s (March 3) Spring budget, the Pharmaceutical Services Negotiating Committee (PSNC) wrote to chancellor Rishi Sunak to intervene and ensure pharmacies will not be required to repay the £370 million COVID-19 loans.

However, Mr Sunak delivered his financial statement this afternoon with no mention of the sector.

Despite reportedly providing £63 billion for frontline health services during the pandemic, the government “has still not taken this opportunity to commit to paying pharmacies the £400m that they have spent in responding to COVID-19”, PSNC chief executive Simon Dukes said this afternoon (March 3).

“Nor have we had any signs that the NHS wishes to give pharmacy its fair share of the health service’s pandemic funds,” he stressed. “This is exasperating and disappointing.”

Pharmacies “must” have the costs they have incurred staying open during the pandemic and running NHS services “fully covered”, Mr Dukes added.

“PSNC cannot accept any less and we will continue to press this point."

CCA: “Chancellor has broken his promise”

Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA) – which represents the large multiples and supermarket pharmacies – said that by ignoring the sector's plea in today’s budget Mr Sunak “has broken his promise to give NHS ‘whatever resources it needs’ to deal with coronavirus”.

At the same time, he has “let down community pharmacies who desperately need help to cover additional COVID costs”.

“Yet again, community pharmacies have been ignored despite keeping their doors open to deliver NHS care throughout the pandemic,” he said.

“They have had to make huge changes to how they work to ensure that their pharmacies remained open and were COVID safe throughout the year. They also dealt with significant increases in patient demand and shortages of staff due to illness and isolation.”

Mr Harrison repeated the warning that more pharmacies will close if the sector does not receive “fair funding”.

“It is of real concern to me that our members have needed to close branches during the pandemic when the public have needed healthcare on their high streets the most.”

NPA: “Pharmacies penalised”

National Pharmacy Association (NPA) chief executive Mark Lyonette said: “The continuation of financial assistance for parts of the economy that have been forced to close during lockdown is understandable.

“However, it highlights once again the lack of support for pharmacies, which have, in effect, been penalised for staying open,” he said.

“We continue to press for the COVID costs incurred by pharmacies, such as extra staffing at peak periods, to be repaid,” Mr Lyonette added.

 

What should PSNC's next steps be to ensure pharmacy receives fair funding?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007045

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel